23 May 2013
Keywords: gsk, reduces, ceo, remuneration, package, andrew, witty
Article | 16 March 2009
Andrew Witty, the chief executive of UK drug major GlaxoSmithKline, will receive a 17.6% pay rise to increase his basic wage ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 March 2009
22 May 2013
© 2013 thepharmaletter.com